title: Twenty-four hour continuous infusion of amphotericin B for the treatment of suspected or proven fungal infection in haematology patients.
authors.forename: P
authors.initials: P
authors.lastname: Hall
authors.forename: G
authors.initials: G
authors.lastname: Kennedy
authors.forename: J
authors.initials: J
authors.lastname: Morton
authors.forename: G R
authors.initials: GR
authors.lastname: Hill
authors.forename: S
authors.initials: S
authors.lastname: Durrant
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage* / Q000633:toxicity; D000935:Antifungal Agents / Q000627:therapeutic use* / Q000633:toxicity; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D007262:Infusions, Intravenous; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B